Nyhetsrum - PILA PHARMA | beQuoted Nyheter

Pressmeddelanden

2025-08-21 15:55

PILA PHARMA: INVITATION TO LIVE H1 REPORT INTERVIEW AND Q&A PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, invites sharehold...

2025-08-21 15:30

PILA PHARMA ANNOUNCES THE COMPLETION OF REGISTRATION OF SHARES IN THE RIGHTS ISSUE AND ITS ASSOCIATED DIRECTED ISSUES, MARKING THE END OF THE RIGHTS ISSUE PROCESS PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") announced on 23 July 2025 that the rights issue of units that was resolved by the board of directors, subject to the annual...

2025-07-31 15:30

REG

PILA PHARMA announces updated dates for last day of trading with paid subscribed units and first day of trading in new shares PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") announces that the last day of trading in paid subscribed units (Sw. BTU) in connection with the Company's rights issue of...

2025-07-23 08:55

REG

The board of directors of PILA PHARMA has resolved to carry out a directed issue of units to underwriters in the previously ended rights issue THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEE...

2025-07-21 13:45

REG MAR

PILA PHARMA announces the outcome of its oversubscribed rights issue and resolves on a directed issue for over-allotment THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEE...

2025-07-14 13:20

REG

THE LAST DAY OF SUBSCRIPTION OF UNITS IN PILA PHARMA'S RIGHTS ISSUE OF UNITS THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEE...

Visa fler pressmeddelanden